Koss Olinger Consulting LLC purchased a new position in Albemarle Co. (NYSE:ALB – Free Report) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 19,653 shares of the specialty chemicals company’s stock, valued at approximately $1,877,000.
A number of other institutional investors have also made changes to their positions in ALB. WFA Asset Management Corp bought a new position in Albemarle during the first quarter worth about $25,000. First Community Trust NA acquired a new stake in shares of Albemarle in the 2nd quarter valued at approximately $25,000. CVA Family Office LLC boosted its stake in Albemarle by 610.0% during the 2nd quarter. CVA Family Office LLC now owns 284 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 244 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in Albemarle by 2,942.9% during the fourth quarter. Jones Financial Companies Lllp now owns 213 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 206 shares during the period. Finally, First Financial Corp IN bought a new stake in Albemarle in the first quarter valued at approximately $32,000. 92.87% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ALB has been the topic of a number of recent analyst reports. Baird R W cut shares of Albemarle from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 5th. HSBC lowered Albemarle from a “buy” rating to a “hold” rating and set a $95.00 target price on the stock. in a report on Wednesday, July 17th. UBS Group dropped their price target on Albemarle from $124.00 to $109.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 9th. Bank of America decreased their price objective on Albemarle from $135.00 to $126.00 and set a “buy” rating for the company in a research report on Friday, August 2nd. Finally, Royal Bank of Canada lowered their target price on Albemarle from $128.00 to $111.00 and set an “outperform” rating for the company in a research note on Tuesday, August 6th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $117.10.
Albemarle Trading Down 6.9 %
Albemarle stock opened at $76.90 on Friday. The company has a market cap of $9.04 billion, a price-to-earnings ratio of 27.96, a P/E/G ratio of 8.12 and a beta of 1.54. The firm has a 50-day moving average of $89.14 and a 200-day moving average of $109.51. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.67 and a quick ratio of 1.75. Albemarle Co. has a one year low of $71.97 and a one year high of $189.19.
Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The specialty chemicals company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.49). The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. Albemarle had a negative net margin of 6.72% and a positive return on equity of 6.38%. The business’s revenue for the quarter was down 39.7% on a year-over-year basis. During the same period last year, the company posted $7.33 earnings per share. On average, equities analysts expect that Albemarle Co. will post 0.69 earnings per share for the current fiscal year.
Albemarle Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, September 13th will be issued a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a yield of 2.11%. This is an increase from Albemarle’s previous quarterly dividend of $0.40. The ex-dividend date is Friday, September 13th. Albemarle’s payout ratio is presently 58.91%.
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Stories
- Five stocks we like better than Albemarle
- What is MarketRank™? How to Use it
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- The Significance of Brokerage Rankings in Stock Selection
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- How is Compound Interest Calculated?
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.